Delivery Order SPE2DB24D2217-SPE2DB25FJXNT
- Not listed
- The Defense Logistics Agency awarded a $13,846.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsule unit dose packages (30-count) on August 14, 2025, with an ultimate completion date of September 5, 2025. This non-set-aside award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The place of performance...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,846.97 on July 28, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages (30-count) with a completion deadline of August 18, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsules (30-count unit dose packaging) with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price contract is classified as a non-set-aside and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Vyndamax 61 mg capsule unit dose packaging in quantities of 30, valued at $13,846.97. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitive award to the prime contractor. The contract is set for ultimate completion by August 14, 2025, with performance based at AmerisourceBergen's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 12, 2025, by the Defense Logistics Agency for the supply of Vyndamax 61 mg capsules in unit dose packs of 30, with a ceiling value of $13,846.97. This firm fixed-price delivery order, which is not set aside for any particular business category, is scheduled for ultimate completion by September 3, 2025. The award represents a child contract under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $13,846.97 to AmerisourceBergen Drug Corp for the supply of Vyndamax 61 mg capsules (unit dose, 30-count packages) under a firm fixed price contract. The delivery order, awarded on August 5, 2025, with an ultimate completion date of August 26, 2025, represents a non-set-aside competitive award. Performance will be executed at the awardee's facility in Conshohocken, Pennsylvania. This delivery order is a child contract awarded...
- The Defense Logistics Agency awarded a delivery order valued at $13,846.97 to AmerisourceBergen Drug Corp for the supply of Vyndamax 61 mg capsules (unit dose, 30-count packaging) under a firm fixed price contract. This non-set-aside competitive award was issued on August 14, 2025, with an ultimate completion date of September 5, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $13,846.97 to AmerisourceBergen Drug Corp for the supply of Vyndamax 61 mg capsules (unit dose, 30-count packaging) under a firm fixed-price contract. The order was competitively awarded with no set-aside designation and is scheduled for completion by September 3, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order valued at $27,693.94 to AmerisourceBergen Drug Corp for the supply of Vyndamax 61 mg capsule unit dose packages (30-count) on August 14, 2025, with completion targeted for September 5, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award under open procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is fulfilling this order through its location in the same city...
- The Defense Logistics Agency awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages in quantities of 30. The contract utilizes firm fixed pricing with an ultimate completion date of August 8, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same municipality. This...
- SPE2DB24D2217Indefinite Delivery Contract
- SPE2DB24D2217-SPE2DB25FJXNTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $13,846.97 to AmerisourceBergen Drug Corp for the supply of Vyndamax 61 mg capsule unit dose packages (30 count). This firm fixed price, competitively awarded contract with no set-aside designation is scheduled for completion by September 4, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Vyndamax is a branded pharmaceutical used in the treatment of cardiac amyloidosis and represents part of the company's ongoing role as a critical pharmaceutical supplier to federal health systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 through December 2026. This IDC vehicle enables AmerisourceBergen to supply a broad spectrum of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. The company's demonstrated capability to fulfill federal medical procurement requirements through competitive contracting positions it as a key vendor within the DLA's pharmaceutical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.8k | 8/13/25 |